Evidence map›Paper›PMID 38478959›Full record

ArticleACS biomaterials science & engineering2024

Tuning the Biodegradation Rate of Silk Materials via Embedded Enzymes.

Junqi Wu, Kareen A Fajardo Cortes, Chunmei Li, Yushu Wang, Chengchen Guo, Kaveh Momenzadeh, Diana Yeritsyan, Philip Hanna, Aron Lechtig, Ara Nazarian and 2 more

Open access · greenAbstract read
In one paragraph

Article in ACS biomaterials science & engineering, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Silk protein plastics for sustained and controlled drug release.International journal of pharmaceutics · 2026
    Article
  2. Article
  3. Manipulating the Assembly and Architecture of Fibrillar Silk.Advanced materials (Deerfield Beach, Fla.) · 2025
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Junqi WuDepartment of Biomedical Engineering, Tufts University, Medford, Massachusetts 02155, United States.
Kareen A Fajardo CortesDepartment of Biomedical Engineering, Tufts University, Medford, Massachusetts 02155, United States.
Chunmei LiDepartment of Biomedical Engineering, Tufts University, Medford, Massachusetts 02155, United States.
Yushu WangDepartment of Biomedical Engineering, Tufts University, Medford, Massachusetts 02155, United States.
Chengchen GuoDepartment of Biomedical Engineering, Tufts University, Medford, Massachusetts 02155, United States.
Kaveh MomenzadehCenter for Advanced Orthopedic Studies, Beth Israel Deaconess Medical Center, 330 Brookline Ave., RN 115, Boston, Massachusetts 02215, United States.
Diana YeritsyanCenter for Advanced Orthopedic Studies, Beth Israel Deaconess Medical Center, 330 Brookline Ave., RN 115, Boston, Massachusetts 02215, United States.
Philip HannaCenter for Advanced Orthopedic Studies, Beth Israel Deaconess Medical Center, 330 Brookline Ave., RN 115, Boston, Massachusetts 02215, United States.
Aron LechtigCenter for Advanced Orthopedic Studies, Beth Israel Deaconess Medical Center, 330 Brookline Ave., RN 115, Boston, Massachusetts 02215, United States.
Ara NazarianCenter for Advanced Orthopedic Studies, Beth Israel Deaconess Medical Center, 330 Brookline Ave., RN 115, Boston, Massachusetts 02215, United States.
Samuel J LinDivisions of Plastic Surgery and Otolaryngology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, United States.
David L KaplanDepartment of Biomedical Engineering, Tufts University, Medford, Massachusetts 02155, United States.ORCID 0000-0002-9245-7774
Beth Israel Deaconess Medical Center · USTufts University · US

Funding

Tissue Engineering Resource Center: TTDP41EB027062 · NIBIB · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Gordana Vunjak-Novakovic · 2019 to 2026
$12.6M
Degradable orthopedic hardwareR01AR068048 · NIAMS · TUFTS UNIVERSITY MEDFORD · PI KAPLAN, DAVID L., LIN, SAMUEL J · 2015 to 2020
$2.0M
NIAMS NIH HHS R01 AR068048NIBIB NIH HHS P41 EB027062
6 · The paper itself

Abstract

Conventional thinking when designing biodegradable materials and devices is to tune the intrinsic properties and morphological features of the material to regulate their degradation rate, modulating traditional factors such as molecular weight and crystallinity. Since regenerated silk protein can be directly thermoplastically molded to generate robust dense silk plastic-like materials, this approach afforded a new tool to control silk degradation by enabling the mixing of a silk-degrading protease into bulk silk material prior to thermoplastic processing. Here we demonstrate the preparation of these silk-based devices with embedded silk-degrading protease to modulate the degradation based on the internal presence of the enzyme to support silk degradation, as opposed to the traditional surface degradation for silk materials. The degradability of these silk devices with and without embedded protease XIV was assessed both in vitro and in vivo. Ultimately, this new process approach provides direct control of the degradation lifetime of the devices, empowered through internal digestion via water-activated proteases entrained and stabilized during the thermoplastic process.

Indexed as

Biocompatible MaterialsSilkPeptide HydrolasesWaterBiocompatible MaterialsPeptide HydrolasesSilkWaterbioplasticdegradationenzyme embeddingsilk

Identifiers

PMID38478959
PMCPMC12008653
OpenAlexW4392764095

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.